Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzira Influenza Vaccine Immunogenicity and Safety in Adults and Older Adults
NCT01591837Phase 4Completed
- Sponsor
- CSL Seqirus
- Start
- May 2012
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Afluria in influenza, sponsored by CSL Seqirus. Started May 2012; status: completed.
02
Drugs
Afluria
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01591837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01591837.